2024-11-012025-10-312025-10-31false01446252LINIC PLASTICS LIMITED2026-07-2322290falseiso4217:GBPxbrli:pure014462522024-10-31014462522025-10-31014462522024-11-012025-10-31014462522023-10-31014462522024-10-31014462522023-11-012024-10-3101446252bus:SmallEntities2024-11-012025-10-3101446252bus:AuditExempt-NoAccountantsReport2024-11-012025-10-3101446252bus:FullAccounts2024-11-012025-10-3101446252bus:PrivateLimitedCompanyLtd2024-11-012025-10-3101446252core:WithinOneYear2025-10-3101446252core:AfterOneYear2025-10-3101446252core:WithinOneYear2024-10-3101446252core:AfterOneYear2024-10-3101446252core:ShareCapital2025-10-3101446252core:SharePremium2025-10-3101446252core:RevaluationReserve2025-10-3101446252core:OtherReservesSubtotal2025-10-3101446252core:RetainedEarningsAccumulatedLosses2025-10-3101446252core:ShareCapital2024-10-3101446252core:SharePremium2024-10-3101446252core:RevaluationReserve2024-10-3101446252core:OtherReservesSubtotal2024-10-3101446252core:RetainedEarningsAccumulatedLosses2024-10-3101446252core:LandBuildings2025-10-3101446252core:PlantMachinery2025-10-3101446252core:Vehicles2025-10-3101446252core:FurnitureFittings2025-10-3101446252core:OfficeEquipment2025-10-3101446252core:NetGoodwill2025-10-3101446252core:IntangibleAssetsOtherThanGoodwill2025-10-3101446252core:ListedExchangeTraded2025-10-3101446252core:UnlistedNon-exchangeTraded2025-10-3101446252core:LandBuildings2024-10-3101446252core:PlantMachinery2024-10-3101446252core:Vehicles2024-10-3101446252core:FurnitureFittings2024-10-3101446252core:OfficeEquipment2024-10-3101446252core:NetGoodwill2024-10-3101446252core:IntangibleAssetsOtherThanGoodwill2024-10-3101446252core:ListedExchangeTraded2024-10-3101446252core:UnlistedNon-exchangeTraded2024-10-3101446252core:LandBuildings2024-11-012025-10-3101446252core:PlantMachinery2024-11-012025-10-3101446252core:Vehicles2024-11-012025-10-3101446252core:FurnitureFittings2024-11-012025-10-3101446252core:OfficeEquipment2024-11-012025-10-3101446252core:NetGoodwill2024-11-012025-10-3101446252core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3101446252core:ListedExchangeTraded2024-11-012025-10-3101446252core:UnlistedNon-exchangeTraded2024-11-012025-10-3101446252core:MoreThanFiveYears2024-11-012025-10-3101446252core:Non-currentFinancialInstruments2025-10-3101446252core:Non-currentFinancialInstruments2024-10-3101446252dpl:CostSales2024-11-012025-10-3101446252dpl:DistributionCosts2024-11-012025-10-3101446252core:LandBuildings2024-11-012025-10-3101446252core:PlantMachinery2024-11-012025-10-3101446252core:Vehicles2024-11-012025-10-3101446252core:FurnitureFittings2024-11-012025-10-3101446252core:OfficeEquipment2024-11-012025-10-3101446252dpl:AdministrativeExpenses2024-11-012025-10-3101446252core:NetGoodwill2024-11-012025-10-3101446252core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3101446252dpl:GroupUndertakings2024-11-012025-10-3101446252dpl:ParticipatingInterests2024-11-012025-10-3101446252dpl:GroupUndertakingscore:ListedExchangeTraded2024-11-012025-10-3101446252core:ListedExchangeTraded2024-11-012025-10-3101446252dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-11-012025-10-3101446252core:UnlistedNon-exchangeTraded2024-11-012025-10-3101446252dpl:CostSales2023-11-012024-10-3101446252dpl:DistributionCosts2023-11-012024-10-3101446252core:LandBuildings2023-11-012024-10-3101446252core:PlantMachinery2023-11-012024-10-3101446252core:Vehicles2023-11-012024-10-3101446252core:FurnitureFittings2023-11-012024-10-3101446252core:OfficeEquipment2023-11-012024-10-3101446252dpl:AdministrativeExpenses2023-11-012024-10-3101446252core:NetGoodwill2023-11-012024-10-3101446252core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3101446252dpl:GroupUndertakings2023-11-012024-10-3101446252dpl:ParticipatingInterests2023-11-012024-10-3101446252dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-012024-10-3101446252core:ListedExchangeTraded2023-11-012024-10-3101446252dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-012024-10-3101446252core:UnlistedNon-exchangeTraded2023-11-012024-10-3101446252core:NetGoodwill2025-10-3101446252core:IntangibleAssetsOtherThanGoodwill2025-10-3101446252core:LandBuildings2025-10-3101446252core:PlantMachinery2025-10-3101446252core:Vehicles2025-10-3101446252core:FurnitureFittings2025-10-3101446252core:OfficeEquipment2025-10-3101446252core:AfterOneYear2025-10-3101446252core:WithinOneYear2025-10-3101446252core:ListedExchangeTraded2025-10-3101446252core:UnlistedNon-exchangeTraded2025-10-3101446252core:ShareCapital2025-10-3101446252core:SharePremium2025-10-3101446252core:RevaluationReserve2025-10-3101446252core:OtherReservesSubtotal2025-10-3101446252core:RetainedEarningsAccumulatedLosses2025-10-3101446252core:NetGoodwill2024-10-3101446252core:IntangibleAssetsOtherThanGoodwill2024-10-3101446252core:LandBuildings2024-10-3101446252core:PlantMachinery2024-10-3101446252core:Vehicles2024-10-3101446252core:FurnitureFittings2024-10-3101446252core:OfficeEquipment2024-10-3101446252core:AfterOneYear2024-10-3101446252core:WithinOneYear2024-10-3101446252core:ListedExchangeTraded2024-10-3101446252core:UnlistedNon-exchangeTraded2024-10-3101446252core:ShareCapital2024-10-3101446252core:SharePremium2024-10-3101446252core:RevaluationReserve2024-10-3101446252core:OtherReservesSubtotal2024-10-3101446252core:RetainedEarningsAccumulatedLosses2024-10-3101446252core:NetGoodwill2023-10-3101446252core:IntangibleAssetsOtherThanGoodwill2023-10-3101446252core:LandBuildings2023-10-3101446252core:PlantMachinery2023-10-3101446252core:Vehicles2023-10-3101446252core:FurnitureFittings2023-10-3101446252core:OfficeEquipment2023-10-3101446252core:AfterOneYear2023-10-3101446252core:WithinOneYear2023-10-3101446252core:ListedExchangeTraded2023-10-3101446252core:UnlistedNon-exchangeTraded2023-10-3101446252core:ShareCapital2023-10-3101446252core:SharePremium2023-10-3101446252core:RevaluationReserve2023-10-3101446252core:OtherReservesSubtotal2023-10-3101446252core:RetainedEarningsAccumulatedLosses2023-10-3101446252core:AfterOneYear2024-11-012025-10-3101446252core:WithinOneYear2024-11-012025-10-3101446252core:Non-currentFinancialInstrumentscore:CostValuation2024-11-012025-10-3101446252core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-012025-10-3101446252core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-012025-10-3101446252core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-012025-10-3101446252core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-012025-10-3101446252core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-012025-10-3101446252core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3101446252core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3101446252core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3101446252core:Non-currentFinancialInstrumentscore:CostValuation2025-10-3101446252core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-10-3101446252core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-10-3101446252core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-10-3101446252core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-10-3101446252core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-10-3101446252core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-10-3101446252core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-10-3101446252core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-10-3101446252core:Non-currentFinancialInstrumentscore:CostValuation2024-10-3101446252core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-3101446252core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-3101446252core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-3101446252core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-3101446252core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-3101446252core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-3101446252core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-3101446252core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-3101446252bus:Director12024-11-012025-10-3101446252core:FurnitureFittingsToolsEquipment2024-10-3101446252core:FurnitureFittingsToolsEquipment2025-10-3101446252core:FurnitureFittingsToolsEquipment2024-11-012025-10-31014462521bus:Director12024-10-31014462521bus:Director12024-11-012025-10-31014462521bus:Director12025-10-31014462522024-10-31014462522024-11-012025-10-31014462522025-10-31

LINIC PLASTICS LIMITED

Registered Number
01446252
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2025

LINIC PLASTICS LIMITED
Company Information
for the year from 1 November 2024 to 31 October 2025

Director

LI Burdett

Registered Address

Victoria Works 24 Saddington Road
Fleckney
Leicester
LE8 8AW

Registered Number

01446252 (England and Wales)
LINIC PLASTICS LIMITED
Balance Sheet as at
31 October 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets355,28264,521
55,28264,521
Current assets
Stocks469,250100,000
Debtors51,278,0391,242,371
Cash at bank and on hand55,65249,759
1,402,9411,392,130
Creditors amounts falling due within one year6(968,024)(1,030,218)
Net current assets (liabilities)434,917361,912
Total assets less current liabilities490,199426,433
Provisions for liabilities7(7,704)(7,148)
Net assets482,495419,285
Capital and reserves
Called up share capital5,0005,000
Profit and loss account477,495414,285
Shareholders' funds482,495419,285
The financial statements were approved and authorised for issue by the Director on 23 July 2026, and are signed on its behalf by:
LI Burdett
Director
Registered Company No. 01446252
LINIC PLASTICS LIMITED
Notes to the Financial Statements
for the year ended 31 October 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Interest income
Interest income is recognised using the effective interest rate method.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Land and buildings50
Plant and machinery10
Fixtures and fittings10
Vehicles4
Office Equipment4
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20252024
Average number of employees during the year1922
3.Tangible fixed assets

Land & buildings

Plant & machinery

Vehicles

Fixtures & fittings

Total

£££££
Cost or valuation
At 01 November 24201,647693,99153,53512,485961,658
At 31 October 25201,647693,99153,53512,485961,658
Depreciation and impairment
At 01 November 24157,243674,07353,53412,287897,137
Charge for year4,0335,008-1989,239
At 31 October 25161,276679,08153,53412,485906,376
Net book value
At 31 October 2540,37114,9101-55,282
At 31 October 2444,40419,918119864,521
4.Stocks

2025

2024

££
Raw materials and consumables69,250100,000
Total69,250100,000
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables91,02472,575
Amounts owed by group undertakings1,145,8121,133,200
Other debtors19,39916,171
Prepayments and accrued income21,80420,425
Total1,278,0391,242,371
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables42,14545,709
Amounts owed to related parties890,061939,319
Taxation and social security18,89317,298
Other creditors10,82521,642
Accrued liabilities and deferred income6,1006,250
Total968,0241,030,218
7.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)7,7047,148
Total7,7047,148
8.Other commitments
There is a contingent liability in respect of an unlimited guarantee by Linic Plastics Limited with HSBC Bank plc in respect of group companies.
9.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
LI Burdett6,3494,0007729,577
6,3494,0007729,577
The loans are interest free and repayable on demand.